Cargando…
Biomarkers in Medicines Development—From Discovery to Regulatory Qualification and Beyond
Biomarkers are important tools in medicines development and clinical practice. Besides their use in clinical trials, such as for enrichment of patients, monitoring safety or response to treatment, biomarkers are a cornerstone of precision medicine. The European Medicines Agency (EMA) emphasised the...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086587/ https://www.ncbi.nlm.nih.gov/pubmed/35559349 http://dx.doi.org/10.3389/fmed.2022.878942 |